Endoscopic, Portographic, and Hemodynamic Evaluation of Prolonged Propranolol Administration in Pigs with Experimental Portal Hypertension and Esophageal Varices

References

• Lebrec D, DeFleury P, Reuff B, Nahum H, Benhamou J P. Portal hypertension, size of esopha-geal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139–1143
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Groszmann R J, Fisher R L, Conn H O, Atterbury C E, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419–424
   PubMed Web of Science ®Google Scholar
• Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodts J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlation in 100 patients. J Hepatol 1985; 1: 125–139
   PubMed Web of Science ®Google Scholar
• Lebrec D, Nouel O, Corbic M, Benhamou J P. Propranolol—a medical treatment for portal hypertension. Lancet 1980; 2: 180–182
   PubMed Web of Science ®Google Scholar
• Kroeger R J, Groszmann R J. Effect of selective blockade of beta2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model. Gastroenterology 1985; 88: 896–900
   PubMed Web of Science ®Google Scholar
• Lebrec D, Poynard T, Hillon P, Benhamou J P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981; 305: 1371–1374
   PubMed Web of Science ®Google Scholar
• Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron J P, Poupon R, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355–358
   PubMed Web of Science ®Google Scholar
• Burroughs A K, Jenkins W J, Sherlock S, Dunk A, Walt R P, Osuafor T OK, Mackie S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539–1542
   PubMed Web of Science ®Google Scholar
• Cales P, Braillon A, Jiron I, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. J Hepato1 1984; 1: 37–46
   Web of Science ®Google Scholar
• Westaby D, Bihari D J, Gimson A ES, Crossley I R, Williams R. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut 1984; 25: 121–124
   PubMed Web of Science ®Google Scholar
• Bosch J, Masti R, Kravetz D, et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 1200–1205
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Grace N, Groszmann R J, Conn H O, Bermann M M, Patrick M JC, Morse S S, et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986; 6: 101–106
   PubMed Web of Science ®Google Scholar
• Kroeger R J, Groszmann R J. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985; 5: 97–101
   PubMed Web of Science ®Google Scholar
• Kroeger R J, Groszmann R J. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model. Hepatology 1985; 5: 425–430
   PubMed Web of Science ®Google Scholar
• Willems B, Villeneuve J P, Huet P M. Effect of propranolol on hepatic and systemic hemodynamics in doas with chronic bile duct ligation. Hepatology 1986; 6: 92–97
   PubMedGoogle Scholar
• Jenkins S A, Baxter J N, Johnson J N, Devitt P, Shields R. Effect of propranolol on hepatic haemo: dynamics in the cirrhotic and non-cirrhotic rat. Br J Surg 1985; 72: 354–358
   PubMedGoogle Scholar
• Hillon P, Blanchet L, Lebrec D. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats. Clin Sci 1982; 63: 29–32
   Google Scholar
• Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, Audano M. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 1987; 7: 648–653
   PubMed Web of Science ®Google Scholar
• Jensen L S, Krarup N, Larsen J A, Juhl C O, Nielsen T H, Dybdahl H. Chronic portal venous hypertension, The effect on liver blood flow and liver function and the development of esophageal varices. Scand J Gastroenterol 1987; 22: 463–470
   PubMed Web of Science ®Google Scholar
• Jensen L S, Krarup N, Larsen J A, Juhl C, Nielsen T H. Effect of acute portal hypertension on hepa-tosplanchnic hemodynamics and liver function. Scand J Gastroenterol 1986; 21: 568–572
   PubMed Web of Science ®Google Scholar
• Kraml M, Robinson W T. Fluorimetry of propranolol and its glucuronide: applicability, specificity, and limitations. Clin Chem 1978; 24: 169–171
   PubMedGoogle Scholar
• Winkler K, Tygstrup N. Determination of hepatic blood flow in man by cardio green. Scand J Clin Lab Invest 1960; 12: 353–363
   PubMed Web of Science ®Google Scholar
• Hjelm M. A methodological study of the enzymatic determination of galactose in human whole blood, plasma and erythrocytes with galactose oxidase. Clin Chim Acta 1967; 15: 87–96
   Web of Science ®Google Scholar
• Olsen C. An enzymatic fluorimetric micromethod for the determination of acetoacetate, beta-hydroxybutyrate, pyruvate and lactate. Clin Chim Acta 1971; 33: 293–300
   PubMed Web of Science ®Google Scholar
• Bradley S E, Ingelfinger F J, Bradley G P, Curry J J. The estimation of hepatic blood flow in man. J Clin Invest 1945; 24: 890–897
   Web of Science ®Google Scholar
• Winkler K, Bass L, Keiding S, Tygstrup N. The physiologic basis for clearance measurements in hepatology. Scand J Gastroenterol 1979; 14: 439–448
   PubMed Web of Science ®Google Scholar
• Krarup N, Larsen J A. The influence of dye infusion rate and hepatic plasma flow on indocyanide green clearance. Scand J Clin Lab Invest 1976; 36: 183–188
   PubMedGoogle Scholar
• Pine M, Favrot L, Smith S, McDonald K, Chidsey C A. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. Circulation 1975; 52: 886–893
   PubMed Web of Science ®Google Scholar
• Price H L, Cooperman L, Warden J. Control of the splanchnic circulation in man. Role of beta-adrenergic receptors. Circ Res 1967; 21: 333–340
   PubMed Web of Science ®Google Scholar
• Zoli M, Marchesini G, Brunori A, Cordiani M R, Pisi E. Portal venous Row in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis. Hepatology 1986; 6: 1248–1251
   PubMed Web of Science ®Google Scholar
• Rodbard S. Vascular caliber. Cardiology 1975; 60: 4–49
   PubMed Web of Science ®Google Scholar
• Guyton J R, Hartley C J. Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am J Physiol 1985; 248: H540
   PubMed Web of Science ®Google Scholar
• Langille L, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986; 231: 405–407
   PubMed Web of Science ®Google Scholar
• Polio J, Groszmann R J. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis 1986; 6: 318–331
   PubMed Web of Science ®Google Scholar
• McLaren M, Braye S, Fleming J, Karran S, Taylor I. Changes in blood flow, portal pressure, and shunting during the development of cirrhosis in response to beta-blockade. Gut 1987; 28: 663–467
   PubMed Web of Science ®Google Scholar
• Braillon A, Cales P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986; 27: 1204–1209
   PubMed Web of Science ®Google Scholar
• Tarver D, Walt R P, Dunk A A, Jenkins W J, Sherlock S. Precipitation of hepatic encephalopathy by propranolol in cirrhosis. Br Med J 1983; 287: 585
   PubMedGoogle Scholar
• van Buuren H R, van der Velden P C, Koorevaar G, Silberbusch J. Propranolol increases arterial ammonia in liver cirrhosis. Lancet 1982; 2: 951–952
   PubMedGoogle Scholar